Literature DB >> 11606269

T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model.

J D Stone1, J R Cochran, L J Stern.   

Abstract

T-cell activation is essential for initiation and control of immune system function. T cells are activated by interaction of cell-surface antigen receptors with major histocompatibility complex (MHC) proteins on the surface of other cells. Studies using soluble oligomers of MHC-peptide complexes and other types of receptor cross-linking agents have supported an activation mechanism that involves T cell receptor clustering. Receptor clustering induced by incubation of T cells with MHC-peptide oligomers leads to the induction of T-cell activation processes, including downregulation of engaged receptors and upregulation of the cell-surface proteins CD69 and CD25. Dose-response curves for these T-cell activation markers are bell-shaped, with different maxima and midpoints, depending on the valency of the soluble oligomer used. In this study, we have analyzed the activation behavior using a mathematical model that describes the binding of multivalent ligands to cell-surface receptors. We show that a simple equilibrium binding model accurately describes the activation data for CD4(+) T cells treated with MHC-peptide oligomers of varying valency. The model can be used to predict activation and binding behavior for T cells and MHC oligomers with different properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606269      PMCID: PMC1301723          DOI: 10.1016/S0006-3495(01)75899-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  47 in total

Review 1.  The expanding world of co-stimulation: the two-signal model revisited.

Authors:  C A Chambers
Journal:  Trends Immunol       Date:  2001-04       Impact factor: 16.687

2.  Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state.

Authors:  T O Cameron; J R Cochran; B Yassine-Diab; R P Sékaly; L J Stern
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

3.  Receptor proximity, not intermolecular orientation, is critical for triggering T-cell activation.

Authors:  J R Cochran; T O Cameron; J D Stone; J B Lubetsky; L J Stern
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

4.  T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.

Authors:  F Letourneur; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  General analysis of receptor-mediated viral attachment to cell surfaces.

Authors:  T J Wickham; R R Granados; H A Wood; D A Hammer; M L Shuler
Journal:  Biophys J       Date:  1990-12       Impact factor: 4.033

6.  The influence of cell surface receptor clustering on the thermodynamics of ligand binding and the kinetics of its dissociation.

Authors:  C DeLisi; R Chabay
Journal:  Cell Biophys       Date:  1979-06

Review 7.  The multi-subunit interleukin-2 receptor.

Authors:  T A Waldmann
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

8.  Receptor cross-linking and histamine release. II. Interpretation and analysis of anomalous dose response patterns.

Authors:  C Delisi; R P Siraganian
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin.

Authors:  J R Lamb; D D Eckels; P Lake; J N Woody; N Green
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

10.  The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways.

Authors:  B A Irving; A Weiss
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

View more
  18 in total

Review 1.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

Review 2.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

3.  T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy.

Authors:  Shi Zhong; Karolina Malecek; Laura A Johnson; Zhiya Yu; Eleazar Vega-Saenz de Miera; Farbod Darvishian; Katelyn McGary; Kevin Huang; Josh Boyer; Emily Corse; Yongzhao Shao; Steven A Rosenberg; Nicholas P Restifo; Iman Osman; Michelle Krogsgaard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

4.  Bifunctional Janus microparticles with spatially segregated proteins.

Authors:  Jennifer L Tang; Kipp Schoenwald; Daniel Potter; David White; Todd Sulchek
Journal:  Langmuir       Date:  2012-06-18       Impact factor: 3.882

5.  Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs.

Authors:  Rebecca R Pompano; Jianjun Chen; Emily A Verbus; Huifang Han; Arthur Fridman; Tessie McNeely; Joel H Collier; Anita S Chong
Journal:  Adv Healthc Mater       Date:  2014-06-13       Impact factor: 9.933

6.  Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM.

Authors:  Lina Cui; Pavel I Kitov; Gladys C Completo; James C Paulson; David R Bundle
Journal:  Bioconjug Chem       Date:  2011-03-23       Impact factor: 4.774

7.  Tandem gramicidin channels cross-linked by streptavidin.

Authors:  Tatyana I Rokitskaya; Elena A Kotova; Yuri N Antonenko
Journal:  J Gen Physiol       Date:  2003-05       Impact factor: 4.086

Review 8.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

9.  A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumour cytotoxicity.

Authors:  Lin Chen; Ye Tian; Kai Zhan; Anan Chen; Zhiming Weng; Jiao Huang; Yanyan Li; Yongjie Sun; Hongjun Zheng; Yi Li
Journal:  Immunology       Date:  2018-05-07       Impact factor: 7.397

10.  Dissecting FcγR Regulation through a Multivalent Binding Model.

Authors:  Ryan A Robinett; Ning Guan; Anja Lux; Markus Biburger; Falk Nimmerjahn; Aaron S Meyer
Journal:  Cell Syst       Date:  2018-06-27       Impact factor: 10.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.